Drug shortages can be a serious problem, causing delays in treatment, forcing healthcare providers to use less effective alternatives, or even impacting patient safety. This bill matters because it tries to tackle this issue by giving a bit more breathing room to specialized drug manufacturers. If this bill becomes law, when a drug shortage is declared over, these facilities won't have to stop production immediately, helping to fill any remaining gaps in the supply chain and making sure patients can continue to get their needed medications without interruption. Without this law, the risk of a drug shortage immediately reappearing after being 'resolved' could be higher, or the market might struggle to stabilize quickly.